Health Canada
www.hc-sc.gc.ca
Home
> Drugs & Health Products
> Drug Products
> Activities
> Scientific/Expert Advisory Panels
> Bioequivalence Requirements for Gender-Specific Drug Products (GSDP)
Institutional links
-
Back to
-
Explore...
-
Proactive Disclosure
Scientific Advisory Panel on Bioequivalence Requirements for Gender-Specific Drug Products (SAP-GSDP)
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Agenda
Place: Holland Cross, Tower B, Room 2000
Date and Time: June 2nd, 2011 at 2:00pm to 4:00pm
Chairperson: Dr. Jake Thiessen
Science Advisor: Dr. Conrad Pereira
Science and Regulatory Officer: Caroline Hunt
Participants: SAP-GSDP members, Health Canada
- 1. Opening remarks
- Director General, Therapeutic Products Directorate
- 2. Affiliations and Interests / Review of Agenda
- Chair
- 3. Acceptance of Terms of Reference
- SAP-GSDP members
- 4. Deliberations and Answers to General Questions
- SAP-GSDP members
- Deliberations and Answers to Question 1
- Deliberations and Answers to Question 2
- Deliberations and Answers to Question 3
- 5. Closing Remarks and Adjournment of Meeting
- Chair